A wholly owned subsidiary of Eli Lilly and Company

Delivering on the Promise of Genetic Medicine for Every Patient

Kelonia Therapeutics Platform

Kelonia’s iGPS® technology builds on decades of research, development, and technical experience to efficiently deliver genetic cargo only to the desired tissue.

View our Platform